Anavex Life Sciences Corp (AVXL)

[sokol]

Do not be the least bit dissuaded by the usual critics such as AF who are suffering from the Semmelweis effect: We may expect to be hearing the same old opposition arguments: 1. It is a small study and proves nothing (as if there is no such thing as an adaptive and efficient FDA trial). 2. Many other Alzheimer's clinical trials initially showed some promise only later to fail in phase 3 (as if we should not conduct any more clinical trials to treat ALzheimer's -- and ironically at the same time these critics will be writing bits of encouraging reports about amyloid plaque studies by Biogen and others). 3. Anavex is too small and does not have sufficient capital and resources to complete a successful phase three (as if might is always right). 4. The Anavex clinical trial has been conducted in the wilds of Australia of all places (as if this should be a negative). 5. We should be skeptical of this Mc fellow conducting this trial (as if he as never been associated with the likes of Lilly or Big Pharma). 6. That Big Pharma is key to the R&D for genuine innovation and the the role of guardians of our health (as if Big Pharma never does anything to block drug competition such as Pay for Delay -- Google that for more information). 7. That AVXL 2-73 is claimed to treat AZ "symptoms" of all all things (as if this should be a negative -- glossing over the fact that all currently approved FDA drugs for Alzheimer's only treat symptoms -- none of which FDA approved drugs I believe relieve insomnia and anxiety prevalent in the disease).

Yes, there will continue to be opposition. Unfortunately, the Semmelweis syndrome is a disease in itself that is not quickly cured.